SD
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis | International journal of molecular sciences |  | 2022 | 274 | 181 | ||
| Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack | Cell Reports. Medicine | | 2021 | 244 | 219 | ||
| Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study | BMC Infectious Diseases | | 2018 | 545 | 306 | ||
| Replicating viral vector platform exploits alarmin signals for potent CD8(+) T cell-mediated tumour immunotherapy | Nature Communications | | 2017 | 658 | 320 | ||
| La nucléoprotéine est nécessaire à l'immunogénicité des vecteurs vaccinaux basés sur les virus de la chorioméningite lymphocytaire recombinants (rLCMV) | | 2016 | 664 | 229 | |||
| The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector Immunogenicity | Journal of virology |  | 2015 | 605 | 2 | ||
| Developmental and metabolic brain alterations in rats exposed to bisphenol A during gestation and lactation | International journal of developmental neuroscience | | 2011 | 671 | 2 |
